1. Home
  2. FCCO vs TLSI Comparison

FCCO vs TLSI Comparison

Compare FCCO & TLSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Community Corporation

FCCO

First Community Corporation

HOLD

Current Price

$30.07

Market Cap

290.5M

Sector

Finance

ML Signal

HOLD

Logo TriSalus Life Sciences Inc.

TLSI

TriSalus Life Sciences Inc.

HOLD

Current Price

$3.39

Market Cap

270.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FCCO
TLSI
Founded
1994
2010
Country
United States
United States
Employees
N/A
102
Industry
Major Banks
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
290.5M
270.2M
IPO Year
2012
N/A

Fundamental Metrics

Financial Performance
Metric
FCCO
TLSI
Price
$30.07
$3.39
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$7.00
AVG Volume (30 Days)
61.4K
715.2K
Earning Date
04-22-2026
05-12-2026
Dividend Yield
2.16%
N/A
EPS Growth
36.46
N/A
EPS
0.59
N/A
Revenue
$922,000.00
N/A
Revenue This Year
$30.67
$35.45
Revenue Next Year
$5.87
$37.58
P/E Ratio
$51.02
N/A
Revenue Growth
N/A
N/A
52 Week Low
$21.80
$2.20
52 Week High
$31.51
$7.95

Technical Indicators

Market Signals
Indicator
FCCO
TLSI
Relative Strength Index (RSI) 52.26 43.67
Support Level $29.16 $2.20
Resistance Level $31.21 $4.63
Average True Range (ATR) 0.67 0.39
MACD 0.03 0.00
Stochastic Oscillator 56.64 47.63

Price Performance

Historical Comparison
FCCO
TLSI

About FCCO First Community Corporation

First Community Corp is a bank holding company. Along with its subsidiaries, it provides various banking products and services for professionals and small and medium-sized businesses, including consumer and commercial banking, mortgage, brokerage and investment, online banking, and insurance services. The company offers checking, savings, money market, individual retirement, and certificates of deposit accounts, and its lending lines include consumer loans, real estate loans, home improvement loans, home loans, flex loans, construction loans, agricultural loans, and others. The company's reportable segments are: Commercial and Retail Banking, which derives maximum revenue; Mortgage Banking; Investment Advisory and Non-Deposit; and Corporate.

About TLSI TriSalus Life Sciences Inc.

TriSalus Life Sciences Inc is an oncology-focused medical technology business integrating its delivery technology with standard-of-care therapies and its investigational immunotherapeutic, nelitolimod, a class C Toll-like receptor 9 (TRL9) agonist, for patients with solid tumors. The company developed Pressure-Enabled Drug Delivery (PEDD) to overcome high intratumoral pressure and off-target delivery. Its 510(k) cleared device, the TriNav Infusion System using PEDD technology, is used for interventional radiology procedures including transarterial radioembolization (TARE) and transarterial chemoembolization (TACE) in patients with primary liver cancer or liver metastases. It has one reportable segment and generates revenue from sales of PEDD infusion systems, principally related to TriNav.

Share on Social Networks: